February 3, 2025- Cedars-Sinai Intellectual Property Company is partnering with Oxford Science Enterprises (OSE), through a major co-investment initiative. The partnership with OSE, an independent investment company launched as a joint venture with the University of Oxford, will include the ability to co-build and co-invest in future health-tech startups coming out of Oxford.
To initiate the ongoing collaboration, Cedars-Sinai Intellectual Property Company and OSE have invested $2 million in Neu Health, a startup from the University of Oxford. The London-based organization offers a digital smartphone-based neurology-care platform to improve outcomes for Parkinson’s disease and dementia patients. This investment follows Neu Health’s participation in Cedars-Sinai’s 10th Accelerator program last year.
The Neu Health platform, backed by more than a decade of research and clinical validation by University of Oxford, includes a patient app linked to a care team dashboard. The platform uses unique data and artificial intelligence to translate motor and non-motor symptoms as well as cognitive and mental health abilities into objective, actionable information for clinicians. With increasing usage in the United Kingdom, the company will pilot its digital platform at Cedars-Sinai to expand and enter the United States market. The first 150 neurology patients are expected to start using the Neu Health app soon as part of the six-month pilot program.